@article{TAU28290,
author = {Timothy C. Boswell and Daniel S. Elliott and Laureano J. Rangel and Brian J. Linder},
title = {Long-term device survival and quality of life outcomes following artificial urinary sphincter placement},
journal = {Translational Andrology and Urology},
volume = {9},
number = {1},
year = {2019},
keywords = {},
abstract = {Background: Artificial urinary sphincter (AUS) placement is the standard for treatment of severe male stress urinary incontinence (SUI). While there is evidence to suggest satisfactory device survival, there is a paucity of data addressing long-term quality of life outcomes.
Methods: We identified patients who underwent primary AUS placement from 1983 to 2016. We assessed rates of secondary surgery (overall, device infection/erosion, urethral atrophy, malfunction) and factors associated with these endpoints. Quality of life was evaluated by pad usage and Patient Global Impression of Improvement (PGI-I) at various time points from primary surgery. Follow-up was obtained in clinic or by phoned/mailed correspondence.
Results: During the study time frame, 1,154 patients were eligible and included in the analysis. Patients had a median age of 70 years (IQR, 65–75 years) and median follow up of 5.4 years (IQR, 1.6–10.5 years). Overall device survival was 72% at 5 years, 56% at 10 years, 41% at 15 years, and 33% at 20 years. On univariate analysis, variables associated with need for secondary surgery were prior cryotherapy (HR 2.7; 95% CI, 1.6–4.6; P},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/28290}
}